compare the results of tablet and injection tranexamic acid for pigmentation over face
Not Applicable
- Conditions
- Health Condition 1: L811- Chloasma
- Registration Number
- CTRI/2022/07/044450
- Lead Sponsor
- Military hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients aged 18-60 years with clinical diagnosis of melasma.
Exclusion Criteria
1. History of bleeding disorders
2. Patient taking oral anticoagulants, hormonal drugs like estrogen, progesterone, oral contraceptive pills and other female hormonal analogues.
3. Past or family history of thrombotic disease like DVT.
5. Patients with known allergy to tranexamic acid.
6. Pregnant and lactation mothers.
8. Patients with any other facial dermatoses.
9. History of any treatment for melasma in the past 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method